Bayer Targets Lupin Over Generic Natazia
Bayer Pharma AG on Wednesday hit Lupin Ltd. with a patent infringement suit in Delaware federal court, seeking to block the India-based drugmaker's plans to market a generic version of its...To view the full article, register now.
Already a subscriber? Click here to view full article